Levetiracetam is an antiepileptic drug with novel antiepileptic mechanism, in which binding to SV2A, a synapticvesicleprotein, may result in its anticonvulsant activity.
左乙拉西坦是一种新型作用机制的抗癫癎药物,其抗癎机制可能是通过影响突触囊泡蛋白SV2A来实现。
2
The present invention discloses one new kind of polypeptide, human synapticvesicleprotein 9.79, polynucleotides encoding this polypeptide and DNA recombination process to produce the polypeptide.